LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | SNS-032 | 10 | uM | LJP6 | 1 | H13 | 72 | hr | 868 | 687 | 3429 | 0.2003 | -0.1114 |
MDA-MB-231 | SNS-032 | 10 | uM | LJP6 | 2 | H13 | 72 | hr | 868 | 866 | 3652 | 0.2371 | -0.0012 |
MDA-MB-231 | SNS-032 | 10 | uM | LJP6 | 3 | H13 | 72 | hr | 868 | 794 | 3587 | 0.2213 | -0.0427 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 868 | 2415 | 3429 | 0.7041 | 0.6756 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 868 | 2747 | 3652 | 0.7522 | 0.7433 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 868 | 2487 | 3587 | 0.6933 | 0.6723 |
MDA-MB-231 | Afatinib | 0.12 | uM | LJP6 | 1 | G23 | 72 | hr | 868 | 2821 | 3429 | 0.8225 | 0.8122 |
MDA-MB-231 | Afatinib | 0.12 | uM | LJP6 | 2 | G23 | 72 | hr | 868 | 2975 | 3652 | 0.8146 | 0.8116 |
MDA-MB-231 | Afatinib | 0.12 | uM | LJP6 | 3 | G23 | 72 | hr | 868 | 3049 | 3587 | 0.8500 | 0.8473 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 1 | G22 | 72 | hr | 868 | 2813 | 3429 | 0.8202 | 0.8097 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 2 | G22 | 72 | hr | 868 | 3027 | 3652 | 0.8289 | 0.8268 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 3 | G22 | 72 | hr | 868 | 2482 | 3587 | 0.6919 | 0.6706 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 1 | G21 | 72 | hr | 868 | 2455 | 3429 | 0.7158 | 0.6895 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 2 | G21 | 72 | hr | 868 | 2627 | 3652 | 0.7193 | 0.7061 |
MDA-MB-231 | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 868 | 2797 | 3587 | 0.7797 | 0.7711 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 1 | G20 | 72 | hr | 868 | 2252 | 3429 | 0.6566 | 0.6176 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 2 | G20 | 72 | hr | 868 | 2069 | 3652 | 0.5665 | 0.5205 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 3 | G20 | 72 | hr | 868 | 2226 | 3587 | 0.6205 | 0.5841 |
MDA-MB-231 | Afatinib | 10 | uM | LJP6 | 1 | G19 | 72 | hr | 868 | 606 | 3429 | 0.1767 | -0.1659 |
MDA-MB-231 | Afatinib | 10 | uM | LJP6 | 2 | G19 | 72 | hr | 868 | 822 | 3652 | 0.2251 | -0.0260 |
MDA-MB-231 | Afatinib | 10 | uM | LJP6 | 3 | G19 | 72 | hr | 868 | 769 | 3587 | 0.2144 | -0.0575 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 1 | H24 | 72 | hr | 868 | 2409 | 3429 | 0.7024 | 0.6735 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 2 | H24 | 72 | hr | 868 | 2842 | 3652 | 0.7782 | 0.7721 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 3 | H24 | 72 | hr | 868 | 2514 | 3587 | 0.7008 | 0.6811 |
MDA-MB-231 | GSK1904529A | 0.12 | uM | LJP6 | 1 | H23 | 72 | hr | 868 | 2672 | 3429 | 0.7791 | 0.7633 |